NYSE:CLB - Core Laboratories Stock Price, Price Target & More

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories declared a quarterly dividend on Tuesday, April 17th. Investors of record on Friday, April 27th will be given a dividend of $0.55 per share on Tuesday, May 22nd. This represents a $2.20 annualized dividend and a yield of 1.73%. The ex-dividend date of this dividend is Thursday, April 26th. View Core Laboratories' Dividend History.

Core Laboratories (NYSE:CLB) announced its quarterly earnings results on Wednesday, April, 25th. The oil and gas company reported $0.57 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.57. The oil and gas company had revenue of $170 million for the quarter, compared to analysts' expectations of $171.03 million. Core Laboratories had a return on equity of 62.69% and a net margin of 13.24%. The company's revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.42 EPS. View Core Laboratories' Earnings History.

Core Laboratories is scheduled to release their next quarterly earnings announcement on Monday, July, 23rd 2018. View Earnings Estimates for Core Laboratories.

Core Laboratories updated its second quarter earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $0.64-0.66 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.66. The company issued revenue guidance of $177-179 million, compared to the consensus revenue estimate of $178.11 million.

11 Wall Street analysts have issued 12 month price objectives for Core Laboratories' shares. Their predictions range from $96.00 to $136.00. On average, they anticipate Core Laboratories' stock price to reach $113.4940 in the next twelve months. View Analyst Ratings for Core Laboratories.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Liberty Oilfield Services (LBRT), Oceaneering International (OII), FTS International (FTSI), C&J Energy Services (CJ), SemGroup Energy Partners (SEMG), Superior Energy Services (SPN), Keane Group (FRAC), Select Energy Services (WTTR), Frank's International (FI), Mammoth Energy Services (TUSK), Helix Energy Solutions Group (HLX), NCS Multistage (NCSM) and Hurricane Energy (HRCXF).

Media headlines about CLB stock have been trending somewhat positive on Wednesday, Accern Sentiment reports. Accern scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Core Laboratories earned a coverage optimism score of 0.15 on Accern's scale. They also gave headlines about the oil and gas company an impact score of 47.31 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Core Laboratories' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include WCM Investment Management CA (11.39%), BlackRock Inc. (6.94%), Kayne Anderson Rudnick Investment Management LLC (4.92%), Earnest Partners LLC (4.41%), Massachusetts Financial Services Co. MA (4.04%) and Epoch Investment Partners Inc. (2.72%). Company insiders that own Core Laboratories stock include Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.

CLB stock was sold by a variety of institutional investors in the last quarter, including Sustainable Growth Advisers LP, Russell Investments Group Ltd., Millennium Management LLC, Legal & General Group Plc, Envestnet Asset Management Inc., Oppenheimer & Co. Inc., Franklin Resources Inc. and Brinker Capital Inc.. View Insider Buying and Selling for Core Laboratories.

CLB stock was purchased by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Massachusetts Financial Services Co. MA, WCM Investment Management CA, Sei Investments Co., Arosa Capital Management LP, BlackRock Inc., Kayne Anderson Rudnick Investment Management LLC and Epoch Investment Partners Inc.. Company insiders that have bought Core Laboratories stock in the last two years include Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CLB stock can currently be purchased for approximately $127.03.

Core Laboratories has a market capitalization of $5.74 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $2.00 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]